RecruitingNot ApplicableNCT05504928

Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

Effectiveness of a School-centered Primary and Secondary Prevention Program on Prevalence of Latent Rheumatic Heart Disease


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

2,300 participants

Start Date

Jun 1, 2022

Study Type

INTERVENTIONAL

Summary

The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.


Eligibility

Min Age: 5 YearsMax Age: 16 Years

Inclusion Criteria2

  • Age 5-16 years
  • Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.

Exclusion Criteria2

  • Children / primary caregivers not providing informed consent to participate
  • Children not attending Tulsi Secondary Boarding School in Tulsipur.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSchool nurse program

School nurse program providing health care through assessment, intervention and follow-up of group A β-hemolytic streptococcal pharyngitis and facilitation of secondary antibiotic prophylaxis for children with latent rheumatic heart disease.


Locations(1)

Tulsi Secondary Boarding School

Tulsi̇̄pur, Nepal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05504928